Physician profile
Scott A Boschee
NPI 1568663409
$1,357.45
in general payments reported to CMS, 2019-2025
17 companies · $155 in 2025
The $155 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $342 · 2021: $160 · 2022: $341 · 2023: $318 · 2024: $40.63 · 2025: $155.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $514.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $513.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $477.37 | 2021-2025 | Qelbree, Qelbree |
| Corium, LLC | $359.38 | 2021-2023 | Azstarys |
| Sanofi Pasteur INC. | $119.70 | 2025 | |
| Pfizer INC. | $65.19 | 2019 | |
| Neos Therapeutics, LP | $54.57 | 2019 | |
| Tris Pharma INC | $41.16 | 2019-2022 | |
| Vertical Pharmaceuticals, LLC | $36.73 | 2019 | |
| Sobi, INC | $32.90 | 2019-2023 | |
| Hologic Sales and Service, LLC | $28.69 | 2023-2024 | Omni Hysteroscope, Acessa Provu System |
| Kaleo, INC. | $28.51 | 2019 | |
| Merck Sharp & Dohme LLC | $24.03 | 2019 | |
| Rhodes Pharmaceuticals L.P. | $16.74 | 2019 | |
| Shire North American Group INC | $16.57 | 2019 | |
| Arbor Pharmaceuticals, INC. | $15.42 | 2019 | |
| Ironshore Pharmaceuticals INC. | $14.98 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cranial Technologies, INC | $13.17 | 2019 | |
| Circassia INC. | $12.34 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Boschee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.